サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：心不整脈モニタリングデバイスの世界市場-2023-2030
市場調査レポート
商品コード
1217636

心不整脈モニタリングデバイスの世界市場-2023-2030

Global Cardiac Arrhythmia Monitoring Devices Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
心不整脈モニタリングデバイスの世界市場-2023-2030
出版日: 2023年02月14日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

不整脈モニタリングは、不規則な心拍数や心拍リズムの原因や種類を特定するために利用される検査の一種です。心拍数を監視・観察するために利用される装置が、心不整脈モニタリングデバイスです。ホルターモニター、モバイル心臓テレメトリー、ECGデバイスなど、心臓のリズムを監視するために開発された数多くの製品があります。

市場力学

世界の心不整脈モニタリングデバイス市場を牽引する主な要因は、より良い治療のために継続的なモニタリングを必要とする心血管障害の発生率の増加によるスマート心臓モニタリングデバイスに対する需要の高まり、認知度の急上昇、新規製品の発売につながる技術の進歩です。

スマート心臓モニターの新興国市場の開拓とテレカーディオロジー（遠隔心臓診断）の需要の高まりは、市場の成長を促進すると予想されます。

心不整脈モニタリングデバイス市場は、テレカーディオロジー需要の増加、技術の進歩の高まり、高齢者人口の増加、研究開発投資の急増、慢性心疾患数の増加、新興国市場の医療インフラの改善とともに最新技術を用いた新規製品の改善によって牽引されています。

不整脈監視装置は、心臓のリズムを連続的に監視し、病状を適切に管理するために広く使用されています。これらの機器の普及が進むにつれ、政府の取り組みや資金も増加しています。これらの資金は、モニタリング用のスマート心臓モニターやスマートウォッチなど、より発展的な製品の生産に役立てられます。これらの心不整脈モニタリングデバイスの市場は、心血管障害に苦しむ人々の数が増加しているため、世界中で増加しています。さらに、主要企業による技術的に高度な製品の提供も、市場の成長に重要な役割を果たすと予想されます。

これらの心不整脈モニタリングデバイスに関連するさまざまな新製品の発売、調査研究、啓発活動の高まりは、市場の成長に寄与しています。例えば、2021年5月24日、心臓ケアの進歩に焦点を当てたデジタルヘルスケアソリューションの会社であるiRhythm Technologies, Inc.は、2つの新規510（k）クリアランスを発表しました。1つは、より優れたデザインの新しいフラッグシップモニター、もう1つは、人工知能（AI）機能の改善です。新型Zioモニターは患者の快適性を高めるために開発され、AI機能の向上により拍動とリズムの診断精度がさらに改善されます。

不確実な償還政策が市場の成長を妨げると予想されます。

しかし、これらの心臓モニタリング機器に関連する不確実な償還政策は、市場の成長を阻害する可能性がある重要な要因です。臨床医だけでなく患者も、この不確実性のために、これらのモニタリングデバイスの採用をためらっています。

また、心血管障害や病状のモニタリングに使用されるこれらの機器の承認に関する厳しい規則や規制も、心不整脈モニタリング機器市場の成長を阻害する要因となっています。また、スマート心臓モニターやスマートウォッチなどの高度なモニターのコストが高いことも、市場の成長を制限する可能性があります。

COVID-19の影響分析

パンデミックは、世界の財政的な期待、業務、危機対応戦略にマイナスの影響を及ぼしています。COVID-19の発生は、ヘルスケア産業に深刻な影響を及ぼしています。心不整脈監視装置市場は、COVIDにより莫大な損失を経験しました。主要メーカーは様々な研究・臨床試験を開始しました。様々な取り組み、製品の発売、コラボレーション、合併が世界中で行われ、市場の成長を後押ししています。例えば、2022年7月22日、心臓ケアの進歩に焦点を当てたデジタルヘルスケアソリューションの会社であるiRhythm Technologies, Inc.は、USFDAによるZio WatchのZEUSシステム（Zio ECG Utilization Software）の認可を受けることについて発表しました。本システムは、精密医療企業であるVerily社との提携により開発されました。ZEUS Systemは、信頼できる心不整脈サービスと深層学習されたアルゴリズムを組み合わせたものです。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • スマート心電計の開発の増加
      • テレカーディオロジー（遠隔心臓診断）の需要増加
    • 抑制要因
      • 不透明な償還政策
    • ビジネスチャンス
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • プライシング分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 製品別

  • ホルターモニター
  • 心電図デバイス
  • モバイル心臓テレメトリー
  • 心臓イベントモニター
  • 植込み型ループレコーダー
  • パッチモニター
  • ペースメーカー
  • 心電除細動器

第8章 アプリケーション別

  • 心房細動
  • 徐脈
  • 心房頻拍
  • 心室性頻拍
  • 心室細動
  • 早発性収縮
  • その他

第9章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 診断センター
  • 専門クリニック

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第12章 企業プロファイル

  • Philips Healthcare
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • GE Healthcare
  • Medtronic PLC
  • Cardiac Sense
  • BIOTRONIK
  • iRhythm Technologies, Inc.
  • Preventice Solutions（Boston Scientific Corporation）
  • Medi-Lynx Cardiac Monitoring LLC.
  • ACS Diagnostics
  • Abbott

第13章 心不整脈モニタリングデバイスの世界市場-DataM

目次
Product Code: DMMD1281

Market Overview

The global cardiac arrhythmia monitoring devices market size was valued at US$ XX million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of YY% during the forecast period (2023-2030).

Cardiac arrhythmia monitoring is a kind of test utilized to determine the cause and type of the irregular heart rates or heart rhythms. The devices utilized to monitor or observe the heart rates are the cardiac arrhythmia monitoring devices. There are numerous products developed for monitoring the heart rhythms including holter monitor, mobile cardiac telemetry or ECG devices.

Market Dynamics

The major factors driving the global cardiac arrhythmia monitoring devices market are the rising demand for smart cardiac monitoring devices owing to increasing incidences of cardiovascular disorders requiring continuous monitoring for better treatment, surging awareness initiatives, advancements in technologies leading to novel product launches.

The increasing development of smart cardiac monitors and rising demand for telecardiology are expected to drive the market's growth.

The cardiac arrhythmia monitoring devices market is driven by increasing demand of telecardiology, rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of chronic cardiovascular diseases and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The cardiac arrhythmia monitoring devices are used widely for continuous monitoring of rhythms of heart for management of the condition properly. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce more developed products such as smart cardiac monitors or smart watches for monitoring. The market for these cardiac arrhythmia monitoring devices is increasing worldwide due to the enhanced number of people suffering from cardiovascular disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives related to these cardiac arrhythmia monitoring devices contribute to the market's growth. For instance, in May 24, 2021, iRhythm Technologies, Inc., a company of digital healthcare solutions focused on cardiac care advancement announced two novel 510(k) clearances. One for a novel flagship monitors with better design and second for an improved artificial intelligence (AI) capabilities. The novel Zio monitor is developed to enhance patient comfort while its AI capabilities advancements will further improve beat and rhythm diagnostic accuracy.

Uncertain reimbursement policies are expected to hamper the market's growth.

However uncertain reimbursement policies associated with these cardiac monitoring devices is the key factor which may hamper the market growth. Due to the uncertainty clinicians as well as patients hesitate in adopting these monitoring devices.

The strict rules and regulations for the approval of these devices utilized for monitoring of cardiovascular disorders or conditions is also a factor hindering the growth of the cardiac arrhythmia monitoring devices market. High costs of highly advanced monitors such as smart cardiac monitors or smart watches can also limit the growth of the market.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The cardiac arrhythmia monitoring devices market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, July 22, 2022, iRhythm Technologies, Inc., a company of digital healthcare solutions focused on cardiac care advancement announced about receiving clearance for Zio Watch's ZEUS System (Zio ECG Utilization Software) by USFDA. This system is developed in partnership with Verily, a precision health company. ZEUS System combines trusted cardiac arrhythmia service with deep learned algorithms.

Segment Analysis

The holter monitors segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The holter monitor segment is the highest market holder in the global cardiac arrhythmia monitoring devices market. The global cardiac arrhythmia monitoring devices market is segmented based on product as holter monitors, ECG devices, mobile cardiac telemetry, cardiac event monitors, implantable loop recorders, patch monitor, pacemaker, cardioverter-defibrillator. The holter monitors segment is the largest market shareholder due to the increasing adoption of these devices globally for monitoring, increasing technological advancements and novel product launches.

Holter monitors are the small and wearable device that records the rhythm of heart. It is utilized to determine or detect irregular heartbeats (arrhythmias) risk. Holter monitors test is usually done if a traditional electrocardiogram is unable to provide sufficient details about the condition of the heart. These monitors can spot irregular heart rhythms that may be missed by ECG. Holter monitoring is non-invasive and painless. The monitor is usually worn for 1 to 2 days in which all the heartbeats are recorded by the device. The sensors and the wires are easy to hide under clothing. The device can be attached to a strap or worn on a belt.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drives the market's growth. For instance, in January 26, 2022, Royal Philips, a health technology company announced about introducing the first at-home, full-service, 12-lead electrocardiogram (ECG) solution that can be utilized in decentralized clinical trials. This clinical-grade solution is the highly advanced patient-centric ECG included within the cardiac monitoring portfolio of Philips, site-based ECGs with leading cloud-based data collection and evaluation services of Philips.

Geographical Analysis

North America holds the largest market share in the global cardiac arrhythmia monitoring devices market.

North America dominates the global cardiac arrhythmia monitoring devices market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of cardiac arrhythmia monitoring devices such as pacemaker, event monitors, ECG devices or holter monitors, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the cardiac arrhythmia monitoring devices market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in February 10, 2021, CardiacSense, a digital health company involved in developing a medical grade watch announced about receiving the CE Mark for its medical grade smart watch device's marketing & sales in the European Union. The certified indications include Heart Rate Variability (HRV) monitoring and detection of Atrial Fibrillation (A-Fib) with spot Electrocardiogram (ECG) and continuous Photoplethysmography (PPG).

Competitive Landscape

The cardiac arrhythmia monitoring devices market is moderately competitive with local and global companies' presence. Philips Healthcare, GE Healthcare, Medtronic PLC, Cardiac Sense, BIOTRONIK, iRhythm Technologies, Inc., Preventice Solutions (Boston Scientific Corporation), Medi-Lynx Cardiac Monitoring, LLC., ACS Diagnostics, Abbott and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in January 21, 2021, Boston Scientific announced about entering into a definitive acquisition agreement with Preventice Solutions, Inc., a company offering a whole portfolio of mobile cardiac health solutions and services, including ambulatory cardiac monitors such as long and short-term Holter monitor, mobile cardiac telemetry and cardiac event monitors.

GE Healthcare

Overview: GE Healthcare is a subsidiary of American multinational conglomerate General Electric Company. The company manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures.

Product Portfolio:

CARESCAPE B850 monitor: It incorporates technologically advanced features including smart lead fail and four lead arrhythmia analysis facilitated by EK-Pro algorithm of GE Healthcare. The monitor also provide a broad range of basic or advanced clinical parameters such as regional oximetry (rSO2), plethysmography variability index (PVI), Perfusion Index (PI) and total hemoglobin (SpHb).

Key Development: In July 16, 2022, GE Healthcare announced about introducing portrait mobile continuous wireless wearable sensors patient monitoring solution for supporting clinicians in detecting early patient deterioration.

The global cardiac arrhythmia monitoring devices market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing development of smart cardiac monitors
      • 4.1.1.2. Rising demand for telecardiology
    • 4.1.2. Restraints:
      • 4.1.2.1. Uncertain reimbursement policies
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Holter Monitor *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 7.3. ECG Devices
  • 7.4. Mobile Cardiac Telemetry
  • 7.5. Cardiac Event Monitors
  • 7.6. Implantable Loop Recorders
  • 7.7. Patch Monitor
  • 7.8. Pacemaker
  • 7.9. Cardioverter-Defibrillator

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Atrial Fibrillation *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. Bradycardia
  • 8.4. Atrial Tachycardia
  • 8.5. Ventricular Tachycardia
  • 8.6. Ventricular Fibrillation
  • 8.7. Premature Contraction
  • 8.8. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Diagnostic Centers
  • 9.5. Specialty Clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Philips Healthcare *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. GE Healthcare
  • 12.3. Medtronic PLC
  • 12.4. Cardiac Sense
  • 12.5. BIOTRONIK
  • 12.6. iRhythm Technologies, Inc.
  • 12.7. Preventice Solutions (Boston Scientific Corporation)
  • 12.8. Medi-Lynx Cardiac Monitoring LLC.
  • 12.9. ACS Diagnostics
  • 12.10. Abbott

LIST NOT EXHAUSTIVE

13. Global Cardiac Arrhythmia Monitoring Devices Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Medications
  • 13.3. Contact Us